You can buy or sell ATXI and other stocks, options, ETFs, and crypto commission-free!
Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. Read More The company was founded on February 9, 2015 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
-$0.43 per share